Design of a synthetic leptin agonist: Effects on energy balance, glucose homeostasis, and thermoregulation

Endocrinology

Volumn 141, Issue 7, 2000, Pages 2501-2507

  Rozhavskaya Arena, Marina ^a   Lee, Daniel W ^a   Leinung, Matthew C ^a   Grasso, Patricia ^a  

^a ALBANY MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; GLUCOSE; LEPTIN;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENERGY BALANCE; FEMALE; FOOD INTAKE; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; METABOLIC DISORDER; MOUSE; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN PURIFICATION; THERMOGENESIS; THERMOREGULATION; WEIGHT REDUCTION;

EID: 0034456462     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.141.7.7556     Document Type: Article

References (42)

1. Monogenic disorders of obesity and body fat distribution
2. Leptin and the regulation of body weight in mammals
3. Unraveling the central nervous system pathways underlying respones to leptin
4. The stomach is a source of leptin
5. Nonadipose tissue production of leptin: Leptin as a novel placenta-derived hormone in humans
6. Serum immunoreactive-leptin concentrations in normal weight and obese humans
7. Serum leptin levels in women with anorexia nervosa
8. Weight-reducing effects of the plasma protein encoded by the obese gene
9. Role of leptin in the neuroendocrine response to fasting
10. Human leptin levels are pulsatile and inversely related to pituitary-adrenal function
11. A role for leptin and its cognate receptor in haematopoiesis
12. Novel 219/OB receptor isoforms: Possible role of leptin in haematopoesis and reproduction
13. Leptin modulates the T-cell immune response and reverses starvation induced immunosuppression
14. Obese, a new mutation in the house mouse
15. Effects of the obese gene product on body weight regulation in ob/ob mice
16. Recombinant ob protein reduces feeding and body weight in the ob/ob mouse
17. Leptin is a metabolic signal to the reproductive system
18. In vivo effects of leptin-related synthetic peptides on body weight and food intake in female ob/ob mice: Localization of leptin activity to domains between amino acid residues 106-140
19. Epitope mapping of secreted mouse leptin utilizing peripherally administered synthetic peptides
20. Inhibitory effects of leptin-related synthetic peptide 116-130 on food intake and body weight gain in female C57BL/6J ob/ob mice may not be mediated by peptide activation of the long isoform of the leptin receptor
21. 116-130 stimulates prolactin and luteinizmg hormone secretion in fasted adult male rats
22. Leptin (116-130) enhances the proliferative activity of immature rat adrenal cortex
23. Recombinant leptin OB protein: Evidence for a peripheral signal linking adiposity and central neural networks
24. Solid phase peptide synthesis. I. The synthesis of a tetrapeptide
25. Rodent mutant models of obesity and their correlations to human obesity
26. Strategies and molecular targets for obesity treatment
27. The role of leptin in human obesity and disease: A review of current evidence
28. Overexpression of the obese (ob) gene in adipose tissue of human obese subjects
29. Decreased cerebrospinal fired/serum leptin ratio in obesity: A possible mechanism for leptin resistance
30. Cerebrospinal fluid leptin levels: Relationship to plasma levels, and to adiposity in humans
31. Design of minimally active fragments of biologically active peptides
32. Binding in the growth hormone-receptor complex
33. Synthetic peptides corresponding to residues
34. Design of novel synthetic peptides including cyclic conformationally and topographically constrained analogs
35. Conformational and topographical considerations in the design of biologically active peptides
36. Structure-activity relationships of C-terminal endothelein hexapeptide antagonists
37. Evaluation of the stability of peptides and pseudopeptides as a tool in peptide drug design
38. Neuropeptide Y: Y1 and Y2 affinities of the complete series of analogues with single D-residue substitutions
39. D-Val22 containing human big endothelin-1 analog, [D-Val22]big ET-1[16-38], inhibits the endothelin converting enzyme
40. D-Amino acid substitution of residues 32 to 46 of the glycoprotein hormone common α-subunit: Development of a synthetic glycoprotein hormone antagonist
41. Computational molecular modeling in peptide drug design
42. Leptin increases uncoupling protein expression and energy expenditure